{"entity":{"type":"insider","cik":"0001821198","url":"/insider/0001821198","json_url":"/insider/0001821198.json","name":"Gollob Jared","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":46,"n_filings":14,"first":"2021-02-19","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Gollob Jared","source":"filing","n_filings":14,"first_seen":"2021-02-19","last_seen":"2026-03-04"}],"transactions":[{"id":6001433,"accession":"0001193125-26-091983","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193125-26-091983","line_url":"/filing/0001193125-26-091983","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4895.0,"shares_display":"4,895","price_per_share":85.29541908069459,"price_display":"85.30","price_state":"stated","total_value":417521.0764,"total_display":"417,521.08","total_whole":"417,521","shares_owned_after":119018.0,"shares_owned_after_display":"119,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-04","scope":"insider","n_lines":4},{"id":6001420,"accession":"0001193125-26-091983","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-091983","line_url":"/filing/0001193125-26-091983","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5613.0,"shares_display":"5,613","price_per_share":88.92705081061821,"price_display":"88.93","price_state":"stated","total_value":499147.5362,"total_display":"499,147.54","total_whole":"499,148","shares_owned_after":122029.0,"shares_owned_after_display":"122,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":3},{"id":4702134,"accession":"0001193125-25-311503","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-311503","line_url":"/filing/0001193125-25-311503","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49307.0,"shares_display":"49,307","price_per_share":88.66555534102663,"price_display":"88.67","price_state":"stated","total_value":4371832.5372,"total_display":"4,371,832.54","total_whole":"4,371,833","shares_owned_after":127183.0,"shares_owned_after_display":"127,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-08","scope":"insider","n_lines":6},{"id":4906094,"accession":"0001193125-25-240430","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-240430","line_url":"/filing/0001193125-25-240430","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59576.0,"shares_display":"59,576","price_per_share":61.42161172116288,"price_display":"61.42","price_state":"stated","total_value":3659253.9399,"total_display":"3,659,253.94","total_whole":"3,659,254","shares_owned_after":140304.0,"shares_owned_after_display":"140,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-15","scope":"insider","n_lines":4},{"id":4531487,"accession":"0001193125-25-239144","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-239144","line_url":"/filing/0001193125-25-239144#line-3","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3114.0,"shares_display":"3,114","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":186840.0,"total_display":"186,840.00","total_whole":"186,840","shares_owned_after":118359.0,"shares_owned_after_display":"118,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-14","scope":"insider"},{"id":4059373,"accession":"0000950170-25-031144","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-031144","line_url":"/filing/0000950170-25-031144","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5740.0,"shares_display":"5,740","price_per_share":30.450442770034844,"price_display":"30.45","price_state":"stated","total_value":174785.5415,"total_display":"174,785.54","total_whole":"174,786","shares_owned_after":121045.0,"shares_owned_after_display":"121,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-03","scope":"insider","n_lines":2},{"id":2827410,"accession":"0000950170-24-084003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-084003","line_url":"/filing/0000950170-24-084003","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23145.0,"shares_display":"23,145","price_per_share":45.807640401814645,"price_display":"45.81","price_state":"stated","total_value":1060217.8371,"total_display":"1,060,217.84","total_whole":"1,060,218","shares_owned_after":105604.0,"shares_owned_after_display":"105,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-16","scope":"insider","n_lines":2},{"id":2827398,"accession":"0000950170-24-084003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-084003","line_url":"/filing/0000950170-24-084003#line-2","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16455.0,"shares_display":"16,455","price_per_share":45.1489,"price_display":"45.15","price_state":"stated","total_value":742925.1495,"total_display":"742,925.15","total_whole":"742,925","shares_owned_after":95740.0,"shares_owned_after_display":"95,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-16","scope":"insider"},{"id":3213677,"accession":"0000950170-24-025101","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-025101","line_url":"/filing/0000950170-24-025101","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3344.0,"shares_display":"3,344","price_per_share":41.85630197368421,"price_display":"41.86","price_state":"stated","total_value":139967.4738,"total_display":"139,967.47","total_whole":"139,967","shares_owned_after":97062.0,"shares_owned_after_display":"97,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-04","scope":"insider","n_lines":3},{"id":3019079,"accession":"0000950170-24-023168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-023168","line_url":"/filing/0000950170-24-023168#line-2","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":74709.0,"shares_owned_after_display":"74,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2341052,"accession":"0000950170-24-013482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-013482","line_url":"/filing/0000950170-24-013482","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46137.0,"shares_display":"46,137","price_per_share":35.50450810845959,"price_display":"35.50","price_state":"stated","total_value":1638071.4906,"total_display":"1,638,071.49","total_whole":"1,638,071","shares_owned_after":82107.0,"shares_owned_after_display":"82,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-09","scope":"insider","n_lines":2},{"id":8032560,"accession":"0000899243-23-006981","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-006981","line_url":"/filing/0000899243-23-006981","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1298.0,"shares_display":"1,298","price_per_share":30.996360169491524,"price_display":"31.00","price_state":"stated","total_value":40233.2755,"total_display":"40,233.28","total_whole":"40,233","shares_owned_after":75006.0,"shares_owned_after_display":"75,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider","n_lines":2},{"id":5038753,"accession":"0000899243-21-042437","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-21-042437","line_url":"/filing/0000899243-21-042437","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14996.0,"shares_display":"14,996","price_per_share":63.22103498266204,"price_display":"63.22","price_state":"stated","total_value":948062.6406,"total_display":"948,062.64","total_whole":"948,063","shares_owned_after":31139.0,"shares_owned_after_display":"31,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-02","scope":"insider","n_lines":3},{"id":5038734,"accession":"0000899243-21-042437","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-042437","line_url":"/filing/0000899243-21-042437","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42497.0,"shares_display":"42,497","price_per_share":61.783073299291715,"price_display":"61.78","price_state":"stated","total_value":2625595.266,"total_display":"2,625,595.27","total_whole":"2,625,595","shares_owned_after":28722.0,"shares_owned_after_display":"28,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-02","scope":"insider","n_lines":4},{"id":4811761,"accession":"0000899243-21-011749","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-011749","line_url":"/filing/0000899243-21-011749#line-4","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10305.0,"shares_display":"10,305","price_per_share":60.17,"price_display":"60.17","price_state":"stated","total_value":620051.85,"total_display":"620,051.85","total_whole":"620,052","shares_owned_after":42547.0,"shares_owned_after_display":"42,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-15","scope":"insider"},{"id":4811755,"accession":"0000899243-21-011749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-011749","line_url":"/filing/0000899243-21-011749#line-2","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4695.0,"shares_display":"4,695","price_per_share":60.0509,"price_display":"60.05","price_state":"stated","total_value":281938.9755,"total_display":"281,938.98","total_whole":"281,939","shares_owned_after":45052.0,"shares_owned_after_display":"45,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-11","filed_date":"2021-03-15","scope":"insider"},{"id":5187305,"accession":"0000899243-21-008085","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-008085","line_url":"/filing/0000899243-21-008085#line-3","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8675.0,"shares_display":"8,675","price_per_share":50.9131,"price_display":"50.91","price_state":"stated","total_value":441671.1425,"total_display":"441,671.14","total_whole":"441,671","shares_owned_after":47547.0,"shares_owned_after_display":"47,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-24","scope":"insider"},{"id":5187300,"accession":"0000899243-21-008085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-008085","line_url":"/filing/0000899243-21-008085#line-2","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19285.0,"shares_display":"19,285","price_per_share":49.6528,"price_display":"49.65","price_state":"stated","total_value":957554.248,"total_display":"957,554.25","total_whole":"957,554","shares_owned_after":56222.0,"shares_owned_after_display":"56,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-23","filed_date":"2021-02-24","scope":"insider"},{"id":5187294,"accession":"0000899243-21-008085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-008085","line_url":"/filing/0000899243-21-008085#line-1","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9104.0,"shares_display":"9,104","price_per_share":52.6285,"price_display":"52.63","price_state":"stated","total_value":479129.864,"total_display":"479,129.86","total_whole":"479,130","shares_owned_after":75507.0,"shares_owned_after_display":"75,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-02-24","scope":"insider"},{"id":5275786,"accession":"0000899243-21-007455","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-007455","line_url":"/filing/0000899243-21-007455#line-3","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8887.0,"shares_display":"8,887","price_per_share":55.0871,"price_display":"55.09","price_state":"stated","total_value":489559.0577,"total_display":"489,559.06","total_whole":"489,559","shares_owned_after":84611.0,"shares_owned_after_display":"84,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-19","scope":"insider"},{"id":5275782,"accession":"0000899243-21-007455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007455","line_url":"/filing/0000899243-21-007455#line-2","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6499.0,"shares_display":"6,499","price_per_share":55.9379,"price_display":"55.94","price_state":"stated","total_value":363540.4121,"total_display":"363,540.41","total_whole":"363,540","shares_owned_after":93498.0,"shares_owned_after_display":"93,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-19","scope":"insider"},{"id":5275778,"accession":"0000899243-21-007455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-007455","line_url":"/filing/0000899243-21-007455#line-1","is_derivative":false,"issuer_cik":"0001815442","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001815442","owner_cik":"0001821198","owner_name":"Gollob Jared","owner_display_name":"Gollob Jared","owner_url":"/insider/0001821198","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7550.0,"shares_display":"7,550","price_per_share":58.3889,"price_display":"58.39","price_state":"stated","total_value":440836.195,"total_display":"440,836.20","total_whole":"440,836","shares_owned_after":99997.0,"shares_owned_after_display":"99,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":46,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Officer (Chief Medical Officer)","n_filings":14,"first_seen":"2021-02-19","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001821198","retrieved_at":"2026-08-23T11:15:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}